CRISPR/Cas9-Mediated Deletion of lpxM and lpxL Reduces Endotoxin Activity in Escherichia coli W3110 Without Compromising Recombinant Protein Production
Genes · 08.11.2026 · 17 (11) · 1415
DOI: 10.3390/genes17111415 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, online erschienen am 08.11.2026. Verfasst von Chentao Zhang und 5 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Background/Objectives: Escherichia coli (E. coli) W3110 is a common host for recombinant protein production. However, lipopolysaccharide (LPS) endotoxin pollution brings extra challenges for downstream purification and safety testing of biotherapeutic proteins. This work set out to build low-endotoxin E. coli mutants by editing lipid A synthesis genes. We further tested their growth profiles, endotoxin levels, and ability to produce recombinant anti-vWF-A1 protein.
Methods
The CRISPR/Cas9 genome-editing system was applied to individually and combinatorially delete lpxM and lpxL, two key genes in lipid A synthesis in E. coli W3110. We characterized bacterial growth kinetics, measured LPS endotoxin activity, expressed anti-vWF-A1 protein in wild-type and mutant strains, and quantified protein yield and residual endotoxin in purified anti-vWF-A1 preparations.
Results
Three mutants, W3110ΔlpxM, W3110ΔlpxL and W3110ΔlpxMΔlpxL, were generated. Deletion of lpxL (single or combined with lpxM) extended the lag phase and decreased the maximum specific growth rate, while ΔlpxM showed only minor growth defects; all strains achieved similar final biomass. LPS endotoxin was markedly reduced in mutants, with the ΔlpxMΔlpxL double mutant showing a 92.1% reduction. When expressing anti-vWF-A1, purified protein from mutants contained significantly less endotoxin, and protein yields were comparable across strains (202–210 mg/L, 96.2–99.5% of wild-type yield).
Conclusions
Deletion of lpxM and lpxL effectively lowers endotoxin loads without substantially compromising recombinant anti-vWF-A1 productivity. This gene-editing strategy provides a feasible route to engineer low-endotoxin E. coli chassis for the manufacture of recombinant therapeutic proteins.
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Zhang, C., Liang, H., Zhang, Y., Wang, X., Zhao, W., & Guo, Y. (2026). CRISPR/Cas9-Mediated Deletion of lpxM and lpxL Reduces Endotoxin Activity in Escherichia coli W3110 Without Compromising Recombinant Protein Production. Genes, 17(11), 1415. https://doi.org/10.3390/genes17111415
Vancouver
Zhang C, Liang H, Zhang Y, Wang X, Zhao W, Guo Y. CRISPR/Cas9-Mediated Deletion of lpxM and lpxL Reduces Endotoxin Activity in Escherichia coli W3110 Without Compromising Recombinant Protein Production. Genes. 2026;17(11):1415. doi:10.3390/genes17111415
BibTeX
@article{Zhang2026,
author = {Zhang, Chentao and Liang, Haozhen and Zhang, Yizhe and Wang, Xiaodi and Zhao, Weiyu and Guo, Yanan},
title = {CRISPR/Cas9-Mediated Deletion of lpxM and lpxL Reduces Endotoxin Activity in Escherichia coli W3110 Without Compromising Recombinant Protein Production},
journal = {Genes},
year = {2026},
volume = {17},
number = {11},
pages = {1415},
doi = {10.3390/genes17111415}
}
EUVIMED